Search the Newsreel

53,769 Shares in The Ensign Group, Inc. $ENSG Bought by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. recently acquired 53,769 shares of The Ensign Group, Inc. (NASDAQ:ENSG), valued at approximately $8.6 million, making them a new institutional investor in the company. Other institutional investors collectively own 96.12% of ENSG. The Ensign Group reported strong Q2 earnings, beating …

Dockside LLC Buys Shares of 13,600 The Ensign Group, Inc. $ENSG

Dockside LLC recently acquired 13,600 shares of The Ensign Group, Inc. (NASDAQ:ENSG) valued at approximately $2.18 million during the second quarter. Other institutional investors have also adjusted their positions in the company, which reported strong quarterly earnings, beating estimates with an EPS of $1.92 …

Ensign Group (ENSG) Stock Dropped 8.15% After Nursing Home Care Allegations; Law Firm Opens Securities Investigation

The Ensign Group, Inc. (NASDAQ: ENSG) is under investigation by Kaplan Fox & Kilsheimer LLP for potential violations of federal securities laws. This follows a report from Hunterbrook Media alleging systemic patient care failures and data manipulation within Ensign's nursing home operations, which caused …

Ensign Group Slides as Short-seller Report Sparks Investor Concern

Ensign Group's stock slid following the release of a short-seller report from Night Market Research. The report alleges that Ensign uses a "predatory business model" involving asset stripping, which has led to significant financial distress for some of its care facilities. Despite these claims, …

Sensient Technologies stock hits all-time high at 132.78 USD By Investing.com

Sensient Technologies (SXT) stock has reached an all-time high of $132.78, trading just below its 52-week high, with a significant surge of over 40% in the past six months and year-to-date. Despite InvestingPro's assessment of the company being overvalued, it has a strong dividend …

EXFY|Expensify Inc|Price:2.165|Chg%:-0.055

PensionBee Group's (PBEE) Buy Rating Reiterated at Canaccord Genuity Group

Ocumension Sets August Board Meeting to Approve Interim Results and Consider Dividend

PensionBee posts 40% revenue surge as assets and customer base grow

Ensign Group (ENSG) President & COO gifts 2,500 shares, retains 65,970

Ensign Group (ENSG) President and COO Burton Spencer gifted 2,500 shares of common stock on August 11, 2026, as reported in a Form 4 filing. This transaction was executed under a Rule 10b5-1 trading plan adopted on February 9, 2026. Following this gift, Spencer …

Expensify (EXFY) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5 p.m. ET CALL PARTICIPANTS Investor Relations - Niki WallrothChief Financial Officer - Ryan SchafferFounder and CEO - David Barrett TAKEAWAYS Revenue -- $33.9 million, representing a 5% decrease year over year driven …

Sensient Technologies (SXT) former major holders reduce beneficial stake to 0%

A group of former major shareholders, including Winder Pte. Ltd., Winder Investment Anstalt, Winder Anstalt, Haldor Foundation, and Freemont Capital Pte. Ltd., have filed an amended Schedule 13G/A, indicating they now beneficially own 0 shares of Sensient Technologies Corp. (SXT). This filing confirms that …

PensionBee Group Q2 2026 TU Earnings Call Transcript

Earnings Flash (PBEE.L) PensionBee Group Reports H1 Revenue GBP26.4M

Intensity Therapeutics (Nasdaq:INTS) - Stock Analysis

Intensity Therapeutics (Nasdaq:INTS) is a late-stage clinical biotechnology company focused on developing INT230-6 for cancer treatment. The company recently provided updates on its INVINCIBLE-4 study for triple-negative breast cancer and the INVINCIBLE-3 study for soft tissue sarcoma, with preliminary positive results and plans for …

Ensign Investor News: If You Have Suffered Losses in The

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. (NASDAQ: ENSG) following allegations of misleading business information. This investigation stems from a short seller report claiming Ensign's business model relies on inadequate patient care and understaffing, leading to an …

Ensign Group (ENSG) Stock Drops 8% After Hunterbrook Media Report as Law Firm Launches Securities Investigation

The Ensign Group (ENSG) saw its stock drop 8% after a Hunterbrook Media report alleged patient care deficiencies and manipulation of quality data in its nursing home operations. Following this, the law firm Kaplan Fox & Kilsheimer LLP launched an investigation into ENSG for …

The Ensign Group, Inc. $ENSG is Wasatch Advisors LP's 2nd Largest Position

Wasatch Advisors LP has significantly increased its stake in The Ensign Group, Inc. (NASDAQ:ENSG), making it their second-largest holding, owning 3.90% of the company worth $365.2 million. Other institutional investors have also adjusted their positions in ENSG. The article also details recent insider stock …

Nano Dimension (NNDM) Projected to Release Earnings on Wednesday

Sensient Technologies (NYSE:SXT) Hits New 12-Month High - What's Next?

Sensient Technologies (NYSE:SXT) recently hit a new 52-week high of $132.47, driven by favorable analyst ratings and strong quarterly earnings. The company exceeded expectations with $1.20 EPS and $462.08 million in revenue, leading analysts like UBS and Robert W. Baird to raise their price …

Intensity Therapeutics reports Q2 2026 net loss of $3.0M, cash $9.5M; resumes select trial enrollment

Intensity Therapeutics reported a net loss of $3.0 million for Q2 2026 and held $9.5 million in cash. The company resumed limited clinical activities for its INVINCIBLE-3 and INVINCIBLE-4 trials, with preliminary INVINCIBLE-4 data showing promising results in pathological complete response and reduced adverse …

Earnings call transcript: Intensity Therapeutics misses Q2 2026 EPS as shares slip premarket

Intensity Therapeutics (INTS) reported a wider-than-expected Q2 2026 loss of $1.11 per share, missing analyst estimates by $0.24, causing its shares to fall 4.62% premarket. The clinical-stage biotech is advancing its INVINCIBLE-3 and INVINCIBLE-4 cancer trials, having secured over $23 million in funding over …

Intensity therapeutics targets INVINCIBLE-4 enrollment completion by end of 2027 while seeking $30M to finish INVINCIBLE-3

Earnings Call Insights: Intensity Therapeutics (INTS) Q2 2026 MANAGEMENT VIEW * "It is my pleasure to provide the latest update of our company's progress in the INVINCIBLE-3 and INVINCIBLE-4 studies, our business development activities, and our plans for the second half of 2026" (Founder, …

Form 8K Intensity Therapeutics Inc For: 11 August By Investing.com

This article reports that Intensity Therapeutics Inc. filed a Form 8K on August 11, 2026. The Form 8K is a crucial document used by public companies to notify investors of significant events that shareholders should know about. No specific details about the content of …

Intensity Therapeutics Q2 Results: EPS loss narrows 67% YoY

INTENSITY THERAPEUTICS, INC. Q2 2026: Net income $(3.0M), EPS $(1.11) — 10-Q Summary

INTENSITY THERAPEUTICS, INC. reported a net loss of $(3.0M) for Q2 2026, an increase from $(2.5M) in Q2 2025, with a diluted loss per share of $(1.11). The company remains pre-revenue but has made progress in its clinical programs, including initiating Phase 3 and …

Sensient Technologies Corporati (SXT) Stock Forecasts

Argus has raised its target price for Sensient Technologies Corp (SXT) to $134.00, citing the company's role as a manufacturer and marketer of natural and synthetic colors, flavors, and other specialty ingredients. The current price of SXT stock is $130.33. This report provides a …

The Ensign Group, Inc. (ENSG) Stock Analysis: Navigating a 20% Potential Upside Amid Strong Revenue Growth

The Ensign Group, Inc. (ENSG) presents a compelling investment opportunity with a potential upside of 20% due to strong revenue growth and positive analyst sentiment. Despite its stock being in overbought territory, the company demonstrates efficient management, profitability, and strategic expansion within the healthcare …

Kaplan Fox Investigates The Ensign Group Over Alleged Securities Violations After Stock Drop

Kaplan Fox & Kilsheimer LLP has launched an investigation into The Ensign Group, Inc. (NASDAQ: ENSG) following a report by Hunterbrook Media alleging inadequate patient care and data misrepresentation. The Hunterbrook Media report, titled "Ensign: The Nursing Home Empire Built On Fatal Neglect," caused …

Ensign Energy Services Inc. (TSX:ESI) Stock Falls as Oilfield Weakness and Investor Caution Pressure Outlook

Ensign Energy Services Q2 Earnings Call Highlights

Nano Dimension(NNDM) Stock Options Chain | Quotes & News

This article provides access to the stock options chain for Nano Dimension (NNDM), including quotes and news. It serves as a resource for investors interested in NNDM's options trading data.

California State Teachers Retirement System Has $3.78 Million Stake in Sensient Technologies Corporation $SXT

The California State Teachers Retirement System increased its stake in Sensient Technologies Corporation (NYSE:SXT) by 26.4% in the first quarter, now holding 43,777 shares valued at $3.78 million. Sensient Technologies exceeded Q1 earnings and revenue expectations, with adjusted EPS of $1.20 and revenue of …